Arylamine N-acetyltransferases in Health and Disease:From Pharmacogenetics to Drug Discovery and Diagnostics (Pharmacology Drug Discovery Ph)

Pay with

About Arylamine N-acetyltransferases In Health And

This book is a fascinating overview of one of the first pharmacogenetic traits to be identified as responsible for genetic variation in response to drugs — the understanding of the arylamine N-acetyltransferases (NATs) is linked to many important therapeutic areas, particularly tuberculosis and also cancer. NATs have been important in the metabolism of established anti-tubercular drugs and also in carcinogenesis and susceptibility to bladder cancer. The reach of these enzymes spans pharmacology and therapeutics as well as toxicology and pharmacogenetics. The NAT genes are encoded in a highly polymorphic region of the human genome which has been explored for fine mapping in molecular anthropological studies.The book takes a wide ranging approach covering all aspects of the arylamine N-acetyltransferases from genetics to the chemistry and structural biology of the enzymes in the organisms in which they are found, from humans to bacteria and fungi where they appear to have distinct roles. The coverage is by experts in the field from across the globe.Contents: Human Arylamine N-acetyltransferases (NATs)Drug Metabolism & Pharmacogenetics Then and NowHuman NAT2: Phenotypic Correlation with Genotype, Clinical PerspectiveHuman NAT2: Genomics for NAT2 PolymorphismsHuman NAT1NAT in OntogenyNATs in TissuesNATs in AnthropologyNATs in Other Eukaryotic OrganismNATs in Primates and in EvolutionTransgenic AnimalsFungal NATsNATs in Prokaryotic OrganismsBacterial NATsMycobacterial NATsNAT and DiseasesHuman NAT2 in Cancer PredictionHuman NAT1 and Breast CancerMycobacterial NATs and TuberculosisNAT NomenclatureReadership: Biotechnology & pharmaceutical industry